58160-0830
Cervarix
Human Papillomavirus Bivalent Vaccine, Recombinant
INJECTION, SUSPENSION
Intramuscular
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN
20.0
ug/.5mL

HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN
20.0
ug/.5mL
58160-0830-01
Oct. 16, 2009
Aug. 24, 2012

58160-0830-05
March 20, 2012
Nov. 29, 2016

58160-0830-11
Oct. 16, 2009
Aug. 24, 2012

58160-0830-32
Oct. 16, 2009
Sept. 3, 2013

58160-0830-34
1 SYRINGE in 1 CARTON (58160-830-34) > .5 mL in 1 SYRINGE (58160-830-05)
March 20, 2012
Nov. 29, 2016

58160-0830-41
July 25, 2011
Sept. 3, 2013

58160-0830-43
July 25, 2011
Nov. 29, 2016

58160-0830-46
Oct. 16, 2009
Sept. 3, 2013

58160-0830-52
10 SYRINGE in 1 CARTON (58160-830-52) > .5 mL in 1 SYRINGE (58160-830-43)
July 25, 2011
Nov. 29, 2016
Ancillary Therapy
Protective Agent
HPV Vaccine
 
No Longer Used